Maverix Biomics has appointed Paul Pickering as COO. Pickering joins Maverix from Life Technologies where he was most recently general manager and head of the Digital PCR Business Unit.
At Maverix, he will manage business functions related to the company's cloud-based analytic platform for next-generation sequencing data.
He holds a master's degree in biochemical engineering from the University of Birmingham, a PhD in biochemical engineering from the University of Bath, and an MBA from Harvard Business School.
The Obama Administration has awarded 13 scientists the Open Science Champions of Change honor, including seven genomic and molecular scientists, Atul Butte, David Altshuler, David Lipman, Drew Endy, John Quackenbush, Kathy Giusti, and Stephen Friend.
Genome Quebec has added three new members to its board of directors, including Christiane Ayotte, Egidio Nascimento, and Jacques Simoneau, while two members, Monique Letourneau and Raymond Langlois, have left the board.
Nascimento is CFO at Variation Biotechnologies, and he has previously served as VP of finance for Genome Canada.
Ayotte is a professor and director of the Doping Control Laboratory at Quebec's INRS Institute.
Simoneau is president and CEO at Gestion Univalor, and he previously held management positions in venture capital and investing at the Solidarity Fund and the Business Development Bank of Canada.